As a Senior Investigator, Dr. Isabella Caniggia is a leading authority on placental development and preeclampsia.
Preeclampsia is the most common complication of pregnancy, affecting seven to 10 per cent of all pregnancies, and
yet there is no cure and the cause is unknown.
Dr. Caniggia and her team have made progress in identifying genetic
alterations, or biomarkers, that predict whether pregnant women will have early- or late-onset preeclampsia. The
earlier preeclampsia is detected, the better the chances for improved health of both mother and child.
